A Study Assessing the Safety and Ocular Hypotensive Efficacy of AR-12286 in Patients With Elevated Intraocular Pressure for 3 Months
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Ocular Hypertension
Related studies linked through entity extraction aliases.
Assessing the Efficacy of DuoTrav as a Replacement Therapy in Glaucoma Patients in Russia
- Status
- WITHDRAWN
- Phase
- PHASE4
Multiple Dose-escalation Study of AMA0076 in Patients With Ocular Hypertension or Primary Open-angle Glaucoma
- Status
- COMPLETED
- Phase
- PHASE2
ATS907 Ph2a Open-Label Dose-ranging Safety and Tolerability in Primary Open Angle Glaucoma (POAG) and Ocular Hypertension (OHT) Subjects
- Status
- COMPLETED
- Phase
- PHASE2
An Efficacy and Tolerability Study of TRAVATAN® Versus LUMIGAN®
- Status
- COMPLETED
- Phase
- PHASE4
Pharmacokinetic and Safety Study of Travoprost 0.004% in Pediatric Glaucoma Patients
- Status
- COMPLETED
- Phase
- PHASE1
24-hour Control of Intraocular Pressure (IOP) in Ocular Hypertension
- Status
- COMPLETED
- Phase
- PHASE4
A Study Comparing IOP-Lowering Treatments to Bimatoprost in Patients With Primary Open Angle Glaucoma or Ocular Hypertension
- Status
- COMPLETED
- Phase
- N/A
A Study of Patients With Primary Open Angle Glaucoma or Ocular Hypertension Who Were Insufficiently Responsive to Monotherapy
- Status
- COMPLETED
- Phase
- N/A
A Study of Lumigan® in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)
- Status
- COMPLETED
- Phase
- N/A
A Study of Intraocular Pressure (IOP) Reduction in Newly Diagnosed Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)
- Status
- COMPLETED
- Phase
- N/A
GANfort® in Patients With Primary Open Angle Glaucoma or Ocular Hypertension Who Are Insufficiently Responsive to Monotherapy
- Status
- COMPLETED
- Phase
- N/A
Lumigan® in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)
- Status
- COMPLETED
- Phase
- N/A
A Safety and Efficacy Study of Bimatoprost 0.01% in Primary Open-Angle Glaucoma (POAG) or Ocular Hypertension (OH)
- Status
- COMPLETED
- Phase
- PHASE4
A Study of Lumigan® 0.01% in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)
- Status
- COMPLETED
- Phase
- N/A
Observational Study of Lumigan® 0.01% for Treatment of Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)
- Status
- COMPLETED
- Phase
- N/A
Safety and Efficacy of LUMIGAN® RC Versus DuoTrav® in Patients Who Require Further Intraocular Pressure (IOP) Reduction
- Status
- COMPLETED
- Phase
- PHASE4
Study Comparing Quantitative Assessments in Open-angle Glaucoma (OAG) and/or Ocular Hypertension (OHT)
- Status
- COMPLETED
- Phase
- N/A
Study of AR-13324 in Patients With Elevated Intraocular Pressure
- Status
- COMPLETED
- Phase
- PHASE2
Study to Evaluate the Safety, Tolerability, and Efficacy of LX7101 in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2